Born 1955 Member of the board of directors since 2024. Member of the Commercialization Committee and the Remuneration Committee.
Professional background: Marianne Kock has extensive experience from Ferring Pharmaceuticals A/S and Novo Nordisk where she has held senior positions. During her 18 years’ tenure in Novo Nordisk A/S, she held leadership positions across the development organization, including as Vice President of Regulatory Support worldwide. She joined Ferring Pharmaceuticals in 2002, where she first served as Senior Vice President of Global Regulatory Affairs and established the R&D activities in Japan and China. Her extensive experience in bringing products from research to launch includes interactions with regulatory authorities worldwide. She was later appointed General Manager for Ferring Pharmaceuticals A/S and where she is now chairperson of the board of directors. She is also board member of several small biotech companies.
Education: Pharmacist and MBA- business
Other ongoing assignments: Board member of Asarina Pharma AB (publ), Biosergen AB and the Danish Chamber of Commerce (Dk. Dansk Erhverv). CEO and board member of Farmaceutisk Laboratorium Ferring A/S. Chairman of Ferring Pharmaceuticals A/S. Member of the management team (Dk. Direktion) in Pharma Insight ApS.
Holdings in Ascelia: View holdings
Independence: Independent in relation to the Company and its management and in relation to major shareholders.